| R Christian Rhoads, NP | |
|
1768 Gateway Blvd Apt 607, Beloit, WI 53511-9815 | |
| (815) 978-0804 | |
| Not Available |
| Full Name | R Christian Rhoads |
|---|---|
| Gender | Male |
| Speciality | Nurse Practitioner |
| Location | 1768 Gateway Blvd Apt 607, Beloit, Wisconsin |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1043494792 | NPI | - | NPPES |
| Entity Name | Froedtert South Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1558305284 PECOS PAC ID: 9537071196 Enrollment ID: O20031103000493 |
News Archive
The Institute for Health Technology Studies has awarded a grant of $240,000 to an international consortium of researchers, for a study that will assess the effects of hip replacement therapy on the employment and retirement decisions of older adults. Led by researchers at the Universit- Bocconi (Milan), the consortium also includes investigators at the University of York (York, UK), and the Johns Hopkins University School of Public Health (Baltimore).
The U.S. Food and Drug Administration today approved Probuphine, the first buprenorphine implant for the maintenance treatment of opioid dependence. Probuphine is designed to provide a constant, low-level dose of buprenorphine for six months in patients who are already stable on low-to-moderate doses of other forms of buprenorphine, as part of a complete treatment program.
250 years ago, over one-fifth of Londoners had contracted syphilis by their 35th birthday, historians have calculated.
An international team of researchers from the University of Rome Tor Vergata and the University of Montreal has reported, in a paper published this week in Nature Communications, the design and synthesis of a nanoscale molecular slingshot made of DNA that is 20,000 times smaller than a human hair.
In this study, published on the medRxiv* preprint server, the humoral response to SARS-CoV-2 was assessed before and after three months of administration of the BNT162b2 mRNA COVID-19 vaccination (Pfizer-BioNTech). In addition, elders' humoral responses were compared to those of a younger group, and a functional neutralization experiment against the Wuhan-Hu-1 (WH1) virus and the Delta variant was carried out.
› Verified 9 days ago
| Entity Name | Ascension Medical Group-southeast Wisconsin Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1609881077 PECOS PAC ID: 8628980943 Enrollment ID: O20031104000421 |
News Archive
The Institute for Health Technology Studies has awarded a grant of $240,000 to an international consortium of researchers, for a study that will assess the effects of hip replacement therapy on the employment and retirement decisions of older adults. Led by researchers at the Universit- Bocconi (Milan), the consortium also includes investigators at the University of York (York, UK), and the Johns Hopkins University School of Public Health (Baltimore).
The U.S. Food and Drug Administration today approved Probuphine, the first buprenorphine implant for the maintenance treatment of opioid dependence. Probuphine is designed to provide a constant, low-level dose of buprenorphine for six months in patients who are already stable on low-to-moderate doses of other forms of buprenorphine, as part of a complete treatment program.
250 years ago, over one-fifth of Londoners had contracted syphilis by their 35th birthday, historians have calculated.
An international team of researchers from the University of Rome Tor Vergata and the University of Montreal has reported, in a paper published this week in Nature Communications, the design and synthesis of a nanoscale molecular slingshot made of DNA that is 20,000 times smaller than a human hair.
In this study, published on the medRxiv* preprint server, the humoral response to SARS-CoV-2 was assessed before and after three months of administration of the BNT162b2 mRNA COVID-19 vaccination (Pfizer-BioNTech). In addition, elders' humoral responses were compared to those of a younger group, and a functional neutralization experiment against the Wuhan-Hu-1 (WH1) virus and the Delta variant was carried out.
› Verified 9 days ago
| Entity Name | Ascension St Francis Hospital Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1225087190 PECOS PAC ID: 0648164194 Enrollment ID: O20040318001377 |
News Archive
The Institute for Health Technology Studies has awarded a grant of $240,000 to an international consortium of researchers, for a study that will assess the effects of hip replacement therapy on the employment and retirement decisions of older adults. Led by researchers at the Universit- Bocconi (Milan), the consortium also includes investigators at the University of York (York, UK), and the Johns Hopkins University School of Public Health (Baltimore).
The U.S. Food and Drug Administration today approved Probuphine, the first buprenorphine implant for the maintenance treatment of opioid dependence. Probuphine is designed to provide a constant, low-level dose of buprenorphine for six months in patients who are already stable on low-to-moderate doses of other forms of buprenorphine, as part of a complete treatment program.
250 years ago, over one-fifth of Londoners had contracted syphilis by their 35th birthday, historians have calculated.
An international team of researchers from the University of Rome Tor Vergata and the University of Montreal has reported, in a paper published this week in Nature Communications, the design and synthesis of a nanoscale molecular slingshot made of DNA that is 20,000 times smaller than a human hair.
In this study, published on the medRxiv* preprint server, the humoral response to SARS-CoV-2 was assessed before and after three months of administration of the BNT162b2 mRNA COVID-19 vaccination (Pfizer-BioNTech). In addition, elders' humoral responses were compared to those of a younger group, and a functional neutralization experiment against the Wuhan-Hu-1 (WH1) virus and the Delta variant was carried out.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| R Christian Rhoads, NP 1768 Gateway Blvd Apt 607, Beloit, WI 53511-9815 Ph: (815) 978-0804 | R Christian Rhoads, NP 1768 Gateway Blvd Apt 607, Beloit, WI 53511-9815 Ph: (815) 978-0804 |
News Archive
The Institute for Health Technology Studies has awarded a grant of $240,000 to an international consortium of researchers, for a study that will assess the effects of hip replacement therapy on the employment and retirement decisions of older adults. Led by researchers at the Universit- Bocconi (Milan), the consortium also includes investigators at the University of York (York, UK), and the Johns Hopkins University School of Public Health (Baltimore).
The U.S. Food and Drug Administration today approved Probuphine, the first buprenorphine implant for the maintenance treatment of opioid dependence. Probuphine is designed to provide a constant, low-level dose of buprenorphine for six months in patients who are already stable on low-to-moderate doses of other forms of buprenorphine, as part of a complete treatment program.
250 years ago, over one-fifth of Londoners had contracted syphilis by their 35th birthday, historians have calculated.
An international team of researchers from the University of Rome Tor Vergata and the University of Montreal has reported, in a paper published this week in Nature Communications, the design and synthesis of a nanoscale molecular slingshot made of DNA that is 20,000 times smaller than a human hair.
In this study, published on the medRxiv* preprint server, the humoral response to SARS-CoV-2 was assessed before and after three months of administration of the BNT162b2 mRNA COVID-19 vaccination (Pfizer-BioNTech). In addition, elders' humoral responses were compared to those of a younger group, and a functional neutralization experiment against the Wuhan-Hu-1 (WH1) virus and the Delta variant was carried out.
› Verified 9 days ago
Madelene G. Hamann, N.P. Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 1905 E Huebbe Pkwy, 1905 E. Huebbe Parkway, Beloit, WI 53511 Phone: 608-364-2240 Fax: 608-363-7374 | |
Cynthia L Philpott, NP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: Beloit Clinic, 1905 E. Huebbe Parkway, Beloit, WI 53511 Phone: 608-364-2400 Fax: 608-363-7389 | |
Malissa R Wightman, RN, APNP Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 2825 Prairie Ave, Beloit, WI 53511 Phone: 608-363-5500 | |
Ms. Cindy I Damon, APNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 1905 E Huebbe Pkwy, Beloit Health System Inc, Beloit, WI 53511 Phone: 608-364-2200 Fax: 608-363-7395 | |
Robert John Derby, NP Nurse Practitioner Medicare: Medicare Enrolled Practice Location: Beloit Clinic, 1905 E Huebbe Parkway, Beloit, WI 53511 Phone: 608-364-1640 Fax: 608-363-7393 | |
Mrs. Tammy Jo Boxleitner, APN Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 1969 West Hart Road, Beloit Memorial Hospital, Inc., Beloit, WI 53511 Phone: 608-364-5011 |